Evidence map›Paper›PMID 40901188›Full record

ArticleAnnals of medicine and surgery (2012)2025

Intracranial hemorrhage in posterior reversible encephalopathy syndrome: a systematic review and meta-analysis.

Bahadar S Srichawla, Mihnea-Alexandru Găman, Hande Can, Vincent Kipkorir, Maria A Garcia-Dominguez

Abstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bahadar S SrichawlaDepartment of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID https://orcid.org/0000-0002-5301-4102
Mihnea-Alexandru GămanFaculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.ORCID https://orcid.org/0000-0001-7133-8875
Hande CanDepartment of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Vincent KipkorirDepartment of Medicine, University of Nairobi, Nairobi, Kenya.
Maria A Garcia-DominguezDepartment of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID https://orcid.org/0000-0002-6588-4113

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Posterior reversible encephalopathy syndrome (PRES) is a clinical-radiographic phenomenon characterized by vasogenic edema, predominantly affecting the posterior regions of the brain. The hemorrhagic variant of PRES has been increasingly recognized, complicating the clinical picture and prognosis. Methods: This meta-analysis was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Observational studies and case reports/series were included. Extracted data included demographics, clinical presentations, imaging findings, and outcomes. A random-effects model to pool the incidence rate of hemorrhagic PRES and heterogeneity was assessed using the I Results: A total of 63 individual records and 12 cohort studies were reviewed. Hypertension at arrival was seen in > 90% of cases. Overall, 60.3% of cases occurred in women and the average age was 39.3, with a 12.7% mortality rate. The incidence rate of hemorrhagic PRES was found to be approximately 17%, with significant heterogeneity among the included studies (I Conclusions: Hemorrhagic PRES is a significant clinical concern, occurring in approximately 17% of PRES cases, and is often associated with poorer outcomes. We highlight the importance of early recognition, aggressive blood pressure control, and careful monitoring in high-risk patients.

Indexed as

intracranial hemorrhageposterior reversible encephalopathy syndrome (PRES)reversible posterior leukoencephalopathy syndrome (RPLS)

Identifiers

PMID40901188
PMCPMC12401445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.